April 12, 2023UBC spinout Aspect inks deal with Novo Nordisk to develop 3-D printed diabetes-curing implants
March 1, 2021First TSX-only biotech IPO in 18 years set for next week as Eupraxia closes books on $41-million offering
January 25, 2021Vancouver’s Khosrowshahi family to launch US$400-million pharma IPO, capitalizing on biotech craze
January 17, 2021Rare milestone approaches for Canadian biotech sector as Aurinia awaits FDA OK to sell new drug
January 7, 2021AbCellera Biologics’s billionaire boss planning hiring spree in Vancouver hometown after record-setting IPO
December 23, 2020opinionWhat Canada needs to do to build a world-class biotech sector Roberto Bellini
December 16, 2020AbCellera closes record biotech IPO as underwriters exercise option to buy shares; total proceeds US$555.5-million
December 7, 2020Vancouver’s AbCellera more than doubles IPO target size, headed for biggest debut on record for Canadian biotech
November 26, 2020Booming Canadian biotech sector on track for record year after raising $1-billion in venture capital so far in 2020
November 19, 2020Peter Thiel joins board of B.C. antibody therapy developer AbCellera in advance of expected IPO
September 14, 2020Canada’s Pascal Biosciences partners with U.S. firm to test cannabis-based cancer therapy
